|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 2002; 39:1083-1095 © 2002 by the American College of Cardiology Foundation |
* Division of Cardiology, Department of Medicine, and the Center for Women’s Health, Columbia University, New York, New York, USA
Manuscript received August 20, 2001; revised manuscript received December 27, 2001, accepted January 11, 2002.
* Reprint requests and correspondence: Dr. Elsa-Grace V. Giardina, Division of Cardiology, Room PH3-346, Department of Medicine, Columbia University, 630 West 168th St., New York, New York 10032, USA.
evg1{at}columbia.edu
Because the use of herbal therapies in the U.S. is escalating, it is essential to be aware of clinical and adverse effects, doses and potential drug-herb interactions. A consumer poll in 1998 indicated that one-third of respondents use botanical remedies, and nearly one in five taking prescription medications also used herbs, high-dose dietary supplements or both. An estimated 15 million adults are at risk for potential adverse interactions involving prescription medications and herbs or vitamin supplements, yet most practicing physicians have little knowledge of herbal remedies or their effects. Herbal products are marketed without the proof of efficacy and safety that the Food and Drug Administration (FDA) requires of drugs. The Dietary Supplement and Health Education Act of 1994 allocates responsibility to manufacturers for ensuring safety and efficacy with no specific requirements to submit documentation. Manufacturers may state a product’s physiologic effects but may not make claims for the treatment or cure of specific diseases. Consumers and practitioners have little information about product safety, contraindications, interactions or effectiveness and are reliant on manufacturers to provide accurate labeling. Recently, the growing number of foods with herbs has raised concerns at the FDA, which requires evidence that food additives are safe. Considering that the growing appeal of herbal remedies is likely to continue, physicians, particularly cardiologists, must become familiar with the available cardiovascular information on herbs. This review highlights the existing data on the efficacy, adverse effects and interactions for herbal therapies that impact on the cardiovascular system.
| ||||||||||||||||||||||||||||||
This article has been cited by other articles:
|
|
 |
|
  L. Y. Lee, W. J. DeBois, K. H. Krieger, and O. W. Isom Transfusion Therapy and Blood Conservation Card. Surg. Adult, January 1, 2008; 3(2008): 415 - 430. [Full Text]
|
|
|
|
 |
|
 D. J. Greenblatt, R. A. Leigh-Pemberton, and L. L. von Moltke In Vitro Interactions of Water-Soluble Garlic Components with Human Cytochromes P450 J. Nutr., March 1, 2006; 136(3): 806S - 809S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Greenblatt, L. L. von Moltke, Y. Luo, E. S. Perloff, K. A. Horan, A. Bruce, R. C. Reynolds, J. S. Harmatz, B. Avula, I. A. Khan, et al. Ginkgo biloba Does Not Alter Clearance of Flurbiprofen, a Cytochrome P450-2C9 Substrate J. Clin. Pharmacol., February 1, 2006; 46(2): 214 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Adawi and L. Walsh Bradycardia and Edema in a Patient Receiving Herbal Therapy for Fertility Ann Intern Med, November 15, 2005; 143(10): 763 - 763. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Fletcher, K. Berra, P. Ades, L. T. Braun, L. E. Burke, J. L. Durstine, J. M. Fair, G. F. Fletcher, D. Goff, L. L. Hayman, et al. Managing Abnormal Blood Lipids: A Collaborative Approach Circulation, November 15, 2005; 112(20): 3184 - 3209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-K. Lee, R. M. Johnke, R. R. Allison, K. F. O'Brien, and L. J. Dobbs Jr Radioprotective potential of ginseng Mutagenesis, July 1, 2005; 20(4): 237 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Greenblatt and L. L. von Moltke Interaction of Warfarin With Drugs, Natural Substances, and Foods J. Clin. Pharmacol., February 1, 2005; 45(2): 127 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Curtis and S. Gaylord Safety Issues in the Interaction of Conventional, Complementary, and Alternative Health Care Complementary Health Practice Review, January 1, 2005; 10(1): 3 - 31. [Abstract] [PDF]
|
|
|
|
|
|
B. J. Maron, B. R. Chaitman, M. J. Ackerman, A. Bayes de Luna, D. Corrado, J. E. Crosson, B. J. Deal, D. J. Driscoll, N.A. M. Estes III, C. G. S. Araujo, et al. Recommendations for Physical Activity and Recreational Sports Participation for Young Patients With Genetic Cardiovascular Diseases Circulation, June 8, 2004; 109(22): 2807 - 2816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Amabile and A. P. Spencer Keeping Your Patient With Heart Failure Safe: A Review of Potentially Dangerous Medications Arch Intern Med, April 12, 2004; 164(7): 709 - 720. [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Zellweger, R. H. Osterwalder, W. Langewitz, and M. E. Pfisterer Coronary artery disease and depression Eur. Heart J., January 1, 2004; 25(1): 3 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Maron Sudden Death in Young Athletes N. Engl. J. Med., September 11, 2003; 349(11): 1064 - 1075. [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Chyka Health Risks of Selected Performance-Enhancing Drugs Journal of Pharmacy Practice, February 1, 2003; 16(1): 37 - 44. [Abstract] [PDF]
|
|
|
|
 |
|
 T. O. Cheng Interaction of herbal drugs with digoxin J. Am. Coll. Cardiol., August 21, 2002; 40(4): 838 - 839. [Full Text] [PDF]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
